Market Research Reports- Consulting Analysis Crystal Market Research Continuous Glucose Monitoring Devices Market by Pr | Page 2

is growing at a higher rate in low and middle income countries. As per International Diabetes Federation, about80% of the diabetic population resides in low and middle income countries. Browse full research report with TOC on “Continuous Glucose Monitoring Devices Market by Application and End User - Global Industry Analysis and Forecast to 2025” at: http://www.crystalmarketresearch.com/report/continuous-glucose-monitoring-devices-market Insulin pumps segment will witness a robust growth during the forecast period, while transmitters and receivers segment occupied a major share of the CGM devices market in 2016.Sensors are disposable components of the CGM systems which need to be replaced every 57 days. Homecare diagnostics segment dominated the global market in 2016, due to high convenience offered byCGM devices in homecare settings for regular monitoring of blood glucose. North America held a major share of the overall market in 2015. This is attributed to factors such as high predominance of diabetes, growing geriatric population, and improving reimbursement policies. U.S. dominated the North American market owing to the presence of advanced healthcare infrastructure and high disposable income of Americans. Asia-Pacific will bring in significant growth opportunities over the forecast period as the awareness about patient monitoring systems is on the rise along with increased healthcare expenditure. Technological advancements are set to drive the competitive CGM devices market during the forecast period. Key players are highly focused on developing innovative products to sustain the market competition. For instance, in September 2015, Medtronic launched the MiniMed connect system enabling smartphone connectivity for CGM. In September 2016, Abbott received FDA approval for Freestyle Libre Pro GGM System designed to provide clear visual snapshots of patients’ glucose levels. In January 2017, Dexcom launched Dexcom CLARITY Diabetes Management Solution in EMEA. This software simplifies CGM data reporting and management. Request a sample copy of Continuous Glucose Monitoring Devices Market Research Report @ http://www.crystalmarketresearch.com/report-sample/HC0621 Major players in the CGM devices market are Dexcom, Inc., Johnson and Johnson, Insulet Corporation, Medtronic, Abbott Laboratories, Echo Therapeutics, Inc., Tandem Diabetes Care, Inc., Nemaura Medical Inc., F. Hoffmann-La Roche AG, Senseonics Holdings, Inc., and GlySens Incorporated. Key Findings of the Research Study: